Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis

被引:92
作者
Sun, Jingxu [1 ]
Song, Yongxi [1 ]
Wang, Zhenning [1 ]
Chen, Xiaowan [1 ]
Gao, Peng [1 ]
Xu, Yingying [1 ]
Zhou, Baosen [2 ]
Xu, Huimian [1 ]
机构
[1] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang 110001, Peoples R China
[2] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110001, Peoples R China
来源
BMC CANCER | 2013年 / 13卷
基金
美国国家科学基金会;
关键词
Gastric cancer; Incurable; Palliative gastrectomy; Metastasis; Meta-analysis; RANDOMIZED CONTROLLED-TRIAL; NON-CURATIVE GASTRECTOMY; DISTANT METASTASIS; SURGICAL-TREATMENT; SUPPORTIVE CARE; RESECTION; CHEMOTHERAPY; EXPERIENCE; SURGERY; PLUS;
D O I
10.1186/1471-2407-13-577
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Palliative gastrectomy for patients with advanced gastric cancer remains controversial. The objective of the present meta-analysis was to analyze survival outcomes and establish a consensus on whether palliative gastrectomy is suitable for patients with incurable advanced gastric cancer and which type of patients should be selected to receive palliative gastrectomy. Methods: A literature search was conducted in PubMed, EMBASE and the Cochrane Library. The results for overall survival in the meta-analysis are expressed as hazard ratios (HRs) with 95% confidence intervals (CIs). Results: Of 1647 articles and abstracts reviewed, 14 studies with 3003 patients were eligible for the final analysis. The meta-analysis revealed that palliative gastrectomy is associated with a significantly improvement in overall survival (HR 0.56; 95%CI 0.39-0.80; p < 0.002) compared that of patients treated without palliative gastrectomy. An improvement in survival was also observed in patients with stage M1 gastric cancer who received palliative gastrectomy (HR 0.62; 95%CI 0.49-0.78; p < 0.0001), especially those with peritoneal dissemination (HR = 0.76, 95%CI 0.63 0.92), liver metastasis (HR = 0.41, 95%CI 0.30-0.55), or distant lymph-node metastasis (HR = 0.36, 95% CI 0.23 0.59). Combined hepatic resection may be beneficial for patients who under palliative gastrectomy (HR 0.30; 95%CI 0.15 0.61; p = 0.0008). The overall survival of patients who underwent palliative gastrectomy combined with chemotherapy was significantly improved (HR 0.63; 95%CI 0.47-0.84; p = 0.002). Conclusions: From the results of the meta-analysis, palliative gastrectomy for patients with incurable advanced gastric cancer may be associated with longer survival, especially for patients with stage M1 gastric cancer. Combined hepatic resection for patients with liver metastasis and chemotherapy may be beneficial factors compared to simple palliative gastrectomy.
引用
收藏
页数:10
相关论文
共 55 条
  • [1] Ajani JA, NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer
  • [2] [Anonymous], 1998, GASTRIC CANCER, V1, P10
  • [3] [Anonymous], 2002, INT UNION CANC UICC
  • [4] A new approach for elimination of gastric cancer deaths in Japan
    Asaka, Masahiro
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (06) : 1272 - 1276
  • [5] Bonenkamp JJ, 2001, HEPATO-GASTROENTEROL, V48, P1219
  • [6] Chang YR, 2011, ANN SURG ONCOL, V19, P1
  • [7] Significance of palliative gastrectomy for late-stage gastric cancer patients
    Chen, Shi
    Li, Yuan-Fang
    Feng, Xing-Yu
    Zhou, Zhi-Wei
    Yuan, Xiu-Hong
    Chen, Ying-Bo
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (07) : 862 - 871
  • [8] Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data
    Chou, I
    Norman, AR
    Cunningham, D
    Waters, JS
    Oates, J
    Ross, PJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2395 - 2403
  • [9] Non-curative gastric resection for patients with stage 4 gastric cancer-a single center experience and current review of literature
    Dittmar, Yves
    Rauchfuss, Falk
    Goetz, Max
    Jandt, Karin
    Scheuerlein, Hubert
    Heise, Michael
    Settmacher, Utz
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2012, 397 (05) : 745 - 753
  • [10] Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan clinical oncology group study JCOG 0705 and korea gastric cancer association study KGCA01
    Fujitani, Kazumasa
    Yang, Han-Kwang
    Kurokawa, Yukinori
    Park, Do Joong
    Tsujinaka, Toshimasa
    Park, Byung-Joo
    Fukuda, Haruhiko
    Noh, Sung Hoon
    Boku, Narikazu
    Bang, Yung-Jue
    Sasako, Mitsuru
    Lee, Jong-Inn
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (07) : 504 - 506